RVL Pharmaceuticals (RVLP) Q2 2023 Earnings

14AugConfirmed
Q3 2022
Q4 2022
Q1 2023
Q2 2023
-0.16
-0.12
-0.09
-0.05

Details

Expected EPS
-0.13
Actual EPS
-0.1
Surprise EPS
0.03
Surprise Percent
+23.08%

Description

RVL Pharmaceuticals (RVLP) has reported earnings of -0.1 per share for Q2 2023.

0 Comments

Share your thoughts